根据ESI于2026年3月发布的数据,我校高被引论文(Highly Cited Papers)737篇,热点论文(Hot Papers)38篇,见附件:2026年3月南方医科大学高被引论文及热点论文简表。详情如下。
从学科角度看,在737篇高被引论文中,临床医学最多(355篇),占比48.17%,药理学与毒理学58篇(7.87%)紧跟其后。
|
序号 |
高被引论文 Research Field |
2026.3 |
2026.1 |
||
|
论文数 |
占比 |
论文数 |
占比 |
||
|
CLINICAL MEDICINE |
355 |
48.17% |
348 |
50.36% |
|
|
2 |
MOLECULAR BIOLOGY & GENETICS |
55 |
7.46% |
49 |
7.09% |
|
3 |
BIOLOGY & BIOCHEMISTRY |
55 |
7.46% |
49 |
7.09% |
|
4 |
PHARMACOLOGY & TOXICOLOGY |
58 |
7.87% |
54 |
7.81% |
|
5 |
MATERIALS SCIENCE |
40 |
5.43% |
39 |
5.64% |
|
6 |
NEUROSCIENCE & BEHAVIOR |
24 |
3.26% |
21 |
3.04% |
|
7 |
ENGINEERING |
13 |
1.76% |
12 |
1.74% |
|
8 |
MICROBIOLOGY |
24 |
3.26% |
21 |
3.04% |
|
9 |
CHEMISTRY |
9 |
1.22% |
8 |
1.16% |
|
10 |
PHYSICS |
39 |
5.29% |
30 |
4.34% |
|
11 |
PSYCHIATRY/PSYCHOLOGY |
13 |
1.76% |
12 |
1.74% |
|
12 |
IMMUNOLOGY |
17 |
2.31% |
15 |
2.17% |
|
13 |
SOCIAL SCIENCES, GENERAL |
10 |
1.36% |
7 |
1.01% |
|
14 |
COMPUTER SCIENCE |
10 |
1.36% |
10 |
1.45% |
|
15 |
AGRICULTURAL SCIENCES |
5 |
0.68% |
5 |
0.72% |
|
16 |
MULTIDISCIPLINARY |
1 |
0.14% |
1 |
0.14% |
|
17 |
ENVIRONMENT/ECOLOGY |
8 |
1.09% |
9 |
1.30% |
|
18 |
MATHEMATICS |
1 |
0.14% |
1 |
0.14% |
|
|
合计 |
737 |
100.00% |
691 |
100.00% |
|
序号 |
2026年3月我校38篇热点论文 标题 |
来源期刊 |
DOI |
Research Field |
Times Cited |
|
1 |
GLOBAL INCIDENCE, PREVALENCE, YEARS LIVED WITH DISABILITY (YLDS), DISABILITY-ADJUSTED LIFE-YEARS (DALYS), AND HEALTHY LIFE EXPECTANCY (HALE) FOR 371 DISEASES AND INJURIES IN 204 COUNTRIES AND TERRITORIES AND 811 SUBNATIONAL LOCATIONS, 1990-2021: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 403 (10440): 2133-2161 MAY 18 2024 |
10.1016/S0140-6736(24)00757-8 |
CLINICAL MEDICINE |
2587 |
|
2 |
MINIMAL INFORMATION FOR STUDIES OF EXTRACELLULAR VESICLES (MISEV2023): FROM BASIC TO ADVANCED APPROACHES |
JOURNAL OF EXTRACELLULAR VESICLES 13 (2): - FEB 7 2024 |
10.1002/jev2.12404 |
BIOLOGY & BIOCHEMISTRY |
1628 |
|
3 |
GLOBAL BURDEN OF 288 CAUSES OF DEATH AND LIFE EXPECTANCY DECOMPOSITION IN 204 COUNTRIES AND TERRITORIES AND 811 SUBNATIONAL LOCATIONS, 1990-2021: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 403 (10440): 2100-2132 MAY 18 2024 |
10.1016/S0140-6736(24)00367-2 |
CLINICAL MEDICINE |
1532 |
|
4 |
GLOBAL BURDEN AND STRENGTH OF EVIDENCE FOR 88 RISK FACTORS IN 204 COUNTRIES AND 811 SUBNATIONAL LOCATIONS, 1990-2021: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 403 (10440): 2162-2203 MAY 18 2024 |
10.1016/S0140-6736(24)00933-4 |
CLINICAL MEDICINE |
1477 |
|
5 |
GLOBAL, REGIONAL, AND NATIONAL BURDEN OF STROKE AND ITS RISK FACTORS, 1990-2021: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET NEUROLOGY 23 (10): 973-1003 OCT 2024 |
10.1016/S1474-4422(24)00369-7 |
NEUROSCIENCE & BEHAVIOR |
506 |
|
6 |
BURDEN OF DISEASE SCENARIOS FOR 204 COUNTRIES AND TERRITORIES, 2022-2050: A FORECASTING ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 403 (10440): 2204-2256 MAY 18 2024 |
10.1016/S0140-6736(24)00685-8 |
CLINICAL MEDICINE |
496 |
|
7 |
USING CLUSTERPROFILER TO CHARACTERIZE MULTIOMICS DATA |
NATURE PROTOCOLS 19 (11): - NOV 2024 |
10.1038/s41596-024-01020-z |
BIOLOGY & BIOCHEMISTRY |
437 |
|
8 |
GLOBAL AGE-SEX-SPECIFIC MORTALITY, LIFE EXPECTANCY, AND POPULATION ESTIMATES IN 204 COUNTRIES AND TERRITORIES AND 811 SUBNATIONAL LOCATIONS, 1950-2021, AND THE IMPACT OF THE COVID-19 PANDEMIC: A COMPREHENSIVE DEMOGRAPHIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 403 (10440): 1989-2056 MAY 18 2024 |
10.1016/S0140-6736(24)00476-8 |
CLINICAL MEDICINE |
407 |
|
9 |
GLOBAL, REGIONAL, AND NATIONAL PREVALENCE OF ADULT OVERWEIGHT AND OBESITY, 1990-2021, WITH FORECASTS TO 2050: A FORECASTING STUDY FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 405 (10481): 813-838 MAR 8 2025 |
10.1016/S0140-6736(25)00355-1 |
CLINICAL MEDICINE |
334 |
|
10 |
ALECTINIB IN RESECTED ALK-POSITIVE NON-SMALL-CELL LUNG CANCER |
NEW ENGLAND JOURNAL OF MEDICINE 390 (14): 1265-1276 APR 11 2024 |
10.1056/NEJMoa2310532 |
CLINICAL MEDICINE |
247 |
|
11 |
GLOBAL FERTILITY IN 204 COUNTRIES AND TERRITORIES, 1950-2021, WITH FORECASTS TO 2100: A COMPREHENSIVE DEMOGRAPHIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
LANCET 403 (10440): 2057-2099 MAY 18 2024 |
10.1016/S0140-6736(24)00550-6 |
CLINICAL MEDICINE |
242 |
|
12 |
PULMONARY HYPERTENSION |
NATURE REVIEWS DISEASE PRIMERS 10 (1): - JAN 4 2024 |
10.1038/s41572-023-00486-7 |
CLINICAL MEDICINE |
187 |
|
13 |
GLOBAL BURDEN OF METABOLIC DISEASES, 1990-2021021 |
METABOLISM-CLINICAL AND EXPERIMENTAL 160: - NOV 2024 |
10.1016/j.metabol.2024.155999 |
BIOLOGY & BIOCHEMISTRY |
157 |
|
14 |
SINGLE-CELL TRANSCRIPTOME ANALYSIS REVEALS THE ASSOCIATION BETWEEN HISTONE LACTYLATION AND CISPLATIN RESISTANCE IN BLADDER CANCER |
DRUG RESISTANCE UPDATES 73: - MAR 2024 |
10.1016/j.drup.2024.101059 |
PHARMACOLOGY & TOXICOLOGY |
138 |
|
15 |
OSTEOARTHRITIS |
NATURE REVIEWS DISEASE PRIMERS 11 (1): - FEB 13 2025 |
10.1038/s41572-025-00594-6 |
CLINICAL MEDICINE |
125 |
|
16 |
TISSUE MACROPHAGES: ORIGIN, HETEROGENITY, BIOLOGICAL FUNCTIONS, DISEASES AND THERAPEUTIC TARGETS |
SIGNAL TRANSDUCTION AND TARGETED THERAPY 10 (1): - MAR 7 2025 |
10.1038/s41392-025-02124-y |
MOLECULAR BIOLOGY & GENETICS |
117 |
|
17 |
TRANSARTERIAL CHEMOEMBOLISATION COMBINED WITH LENVATINIB PLUS PEMBROLIZUMAB VERSUS DUAL PLACEBO FOR UNRESECTABLE, NON-METASTATIC HEPATOCELLULAR CARCINOMA (LEAP-012) : A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PHASE 3 STUDY |
LANCET 405 (10474): 203-215 JAN 18 2025 |
10.1016/S0140-6736(24)02575-3 |
CLINICAL MEDICINE |
113 |
|
18 |
BURDEN OF DISEASE ATTRIBUTABLE TO HIGH BODY MASS INDEX: AN ANALYSIS OF DATA FROM THE GLOBAL BURDEN OF DISEASE STUDY 2021 |
ECLINICALMEDICINE 76: - OCT 2024 |
10.1016/j.eclinm.2024.102848 |
CLINICAL MEDICINE |
109 |
|
19 |
IMLGAM: INTEGRATED MACHINE LEARNING AND GENETIC ALGORITHM-DRIVEN MULTIOMICS ANALYSIS FOR PAN-CANCER IMMUNOTHERAPY RESPONSE PREDICTION |
IMETA 4 (2): - APR 2025 |
10.1002/imt2.70011 |
MICROBIOLOGY |
107 |
|
20 |
SMART GAS SENSORS: RECENT DEVELOPMENTS AND FUTURE PROSPECTIVE |
NANO-MICRO LETTERS 17 (1): - NOV 4 2024 |
10.1007/s40820-024-01543-w |
MATERIALS SCIENCE |
105 |
|
21 |
MONASCUS PIGMENT-PROTECTED BONE MARROW-DERIVED STEM CELLS FOR HEART FAILURE TREATMENT |
BIOACTIVE MATERIALS 42: 270-283 DEC 2024 |
10.1016/j.bioactmat.2024.08.038 |
MATERIALS SCIENCE |
103 |
|
22 |
HISTONE H3K9 LACTYLATION CONFERS TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA VIA LUC7L2-MEDIATED MLH1 INTRON RETENTION |
ADVANCED SCIENCE 11 (19): - MAY 2024 |
10.1002/advs.202309290 |
PHYSICS |
92 |
|
23 |
A METALLIC ROOM-TEMPERATURE D-WAVE ALTERMAGNET |
NATURE PHYSICS 21 (5): - MAY 2025 |
10.1038/s41567-025-02822-y |
PHYSICS |
82 |
|
24 |
USING CU-BASED METAL-ORGANIC FRAMEWORK AS A COMPREHENSIVE AND POWERFUL ANTIOXIDANT NANOZYME FOR EFFICIENT OSTEOARTHRITIS TREATMENT |
ADVANCED SCIENCE 11 (13): - APR 2024 |
10.1002/advs.202307798 |
PHYSICS |
76 |
|
25 |
TURMERIC-DERIVED NANOPARTICLES FUNCTIONALIZED AEROGEL REGULATES MULTICELLULAR NETWORKS TO PROMOTE DIABETIC WOUND HEALING |
ADVANCED SCIENCE 11 (18): - MAY 2024 |
10.1002/advs.202307630 |
PHYSICS |
61 |
|
26 |
MICROSCALE FIBER PHOTOACOUSTIC SPECTROSCOPY FOR IN SITU AND REAL-TIME TRACE GAS SENSING |
ADVANCED PHOTONICS 6 (6): - NOV 1 2024 |
10.1117/1.AP.6.6.066008 |
PHYSICS |
54 |
|
27 |
RECENT ADVANCEMENTS IN HYDROGELS AS NOVEL TISSUE ENGINEERING SCAFFOLDS FOR DENTAL PULP REGENERATION |
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES 264: - PART 2 APR 2024 |
10.1016/j.ijbiomac.2024.130708 |
BIOLOGY & BIOCHEMISTRY |
53 |
|
28 |
MULTIFUNCTIONAL DNA HYDROGELS WITH LIGHT-TRIGGERED GAS-THERAPY AND CONTROLLED G-EXOS RELEASE FOR INFECTED WOUND HEALING |
BIOACTIVE MATERIALS 52: 422-437 OCT 2025 |
10.1016/j.bioactmat.2025.06.004 |
MATERIALS SCIENCE |
42 |
|
29 |
THE BENEFITS AND SAFETY OF MONOCLONAL ANTIBODIES: IMPLICATIONS FOR CANCER IMMUNOTHERAPY |
JOURNAL OF INFLAMMATION RESEARCH 18: 4335-4357 2025 |
10.2147/JIR.S499403 |
IMMUNOLOGY |
26 |
|
30 |
LAYERED DOUBLE HYDROXIDES FOR REGENERATIVE NANOMEDICINE AND TISSUE ENGINEERING: RECENT ADVANCES AND FUTURE PERSPECTIVES |
JOURNAL OF NANOBIOTECHNOLOGY 23 (1): - MAY 22 2025 |
10.1186/s12951-025-03448-1 |
BIOLOGY & BIOCHEMISTRY |
26 |
|
31 |
DOUBLE-SIDED PROTECTOR JANUS HYDROGELS FOR SKIN AND MUCOSAL WOUND REPAIR: APPLICATIONS, MECHANISMS, AND PROSPECTS |
JOURNAL OF NANOBIOTECHNOLOGY 23 (1): - MAY 28 2025 |
10.1186/s12951-025-03438-3 |
BIOLOGY & BIOCHEMISTRY |
25 |
|
32 |
MITOCHONDRIAL PATHWAY SIGNATURE (MITOPS) PREDICTS IMMUNOTHERAPY RESPONSE AND REVEALS NDUFB10 AS A KEY IMMUNE REGULATOR IN LUNG ADENOCARCINOMA |
JOURNAL FOR IMMUNOTHERAPY OF CANCER 13 (7): - JUL 31 2025 |
10.1136/jitc-2025-012069 |
IMMUNOLOGY |
20 |
|
33 |
PIF-NET: A PARALLEL INTERWEAVE FUSION NETWORK FOR KNEE JOINT SEGMENTATION |
BIOMEDICAL SIGNAL PROCESSING AND CONTROL 109: - NOV 2025 |
10.1016/j.bspc.2025.107967 |
ENGINEERING |
16 |
|
34 |
PREDICTIVE VALUE OF REMNANT CHOLESTEROL INFLAMMATORY INDEX FOR STROKE RISK: EVIDENCE FROM THE CHINA HEALTH AND RETIREMENT LONGITUDINAL STUDY |
JOURNAL OF ADVANCED RESEARCH 76: 543-552 OCT 2025 |
10.1016/j.jare.2024.12.015 |
CLINICAL MEDICINE |
16 |
|
35 |
INTEGRATING MULTI-OMICS DATA TO REVEAL THE HOST-MICROBIOTA INTERACTOME IN INFLAMMATORY BOWEL DISEASE |
GUT MICROBES 17 (1): - DEC 31 2025 |
10.1080/19490976.2025.2476570 |
MICROBIOLOGY |
14 |
|
36 |
NATURAL KILLER CELL IMMUNE CHECKPOINTS AND THEIR THERAPEUTIC TARGETING IN CANCER TREATMENT |
RESEARCH 8: - JUN 3 2025 |
10.34133/research.0723 |
IMMUNOLOGY |
13 |
|
37 |
BURDEN OF 375 DISEASES AND INJURIES, RISK-ATTRIBUTABLE BURDEN OF 88 RISK FACTORS, AND HEALTHY LIFE EXPECTANCY IN 204 COUNTRIES AND TERRITORIES, INCLUDING 660 SUBNATIONAL LOCATIONS, 1990-2023: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2023 |
LANCET 406 (10513): 1873-1922 OCT 18 2025 |
10.1016/S0140-6736(25)01637-X |
CLINICAL MEDICINE |
8 |
|
38 |
MICROBIOME MEETS IMMUNOTHERAPY: UNLOCKING THE HIDDEN PREDICTORS OF IMMUNE CHECKPOINT INHIBITORS |
NPJ BIOFILMS AND MICROBIOMES 11 (1): - SEP 2 2025 |
10.1038/s41522-025-00819-2 |
MICROBIOLOGY |
6 |
周一至周日 8:00-22:00
周一至周日 8:00-22:00
电话:020-62789014(本部)
0757-29985219(顺德)
电话:020-61648543
电话:020-61648053
电话:020-62789012
电话:020-61648051
电话:020-62789012
邮政编码:510515
邮政编码:528305
当前IP地址:216.73.216.183
